Join
Live feed
·
PRReleasevia Quantisnow
Oncternal Therapeutics Inc. logo

Oncternal Therapeutics Announces Termination of its Clinical Studies and Exploration of Strategic Alternatives

ByQuantisnow·Wall Street's wire, on your screen.
ONCT· Oncternal Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCT (Oncternal Therapeutics Inc.) and more on Quantisnow.